Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Chlamydia vaccines: recent developments and the role of adjuvants in future formulations.

Igietseme JU, Eko FO, Black CM.

Expert Rev Vaccines. 2011 Nov;10(11):1585-96. doi: 10.1586/erv.11.139. Review.

PMID:
22043957
2.

Delivery of Chlamydia vaccines.

Igietseme J, Eko F, He Q, Bandea C, Lubitz W, Garcia-Sastre A, Black C.

Expert Opin Drug Deliv. 2005 May;2(3):549-62. Review.

PMID:
16296774
3.

Contemporary approaches to designing and evaluating vaccines against Chlamydia.

Igietseme JU, Eko FO, Black CM.

Expert Rev Vaccines. 2003 Feb;2(1):129-46. Review.

PMID:
12901604
4.

Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Sahu R, Verma R, Dixit S, Igietseme JU, Black CM, Duncan S, Singh SR, Dennis VA.

Expert Rev Vaccines. 2018 Mar;17(3):217-227. doi: 10.1080/14760584.2018.1435279. Epub 2018 Feb 6.

PMID:
29382248
5.

Chlamydia vaccine candidates and tools for chlamydial antigen discovery.

Rockey DD, Wang J, Lei L, Zhong G.

Expert Rev Vaccines. 2009 Oct;8(10):1365-77. doi: 10.1586/erv.09.98. Review.

PMID:
19803759
6.

Developing effective delivery systems for Chlamydia vaccines.

Igietseme JU, Eko FO, He Q, Bandea C, Black CM.

Curr Opin Mol Ther. 2004 Apr;6(2):182-94.

PMID:
15195931
7.

Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.

Hickey DK, Aldwell FE, Beagley KW.

Vaccine. 2009 Oct 19;27(44):6217-25. doi: 10.1016/j.vaccine.2009.08.001. Epub 2009 Aug 19.

PMID:
19698810
8.

Chlamydia vaccines: strategies and status.

Igietseme JU, Black CM, Caldwell HD.

BioDrugs. 2002;16(1):19-35. Review.

PMID:
11908999
9.

Vaccines for Chlamydia infections of the female genital tract.

Hafner LM, McNeilly C.

Future Microbiol. 2008 Feb;3(1):67-77. doi: 10.2217/17460913.3.1.67. Review.

PMID:
18230035
10.

Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.

Brown TH, David J, Acosta-Ramirez E, Moore JM, Lee S, Zhong G, Hancock RE, Xing Z, Halperin SA, Wang J.

Vaccine. 2012 Jan 5;30(2):350-60. doi: 10.1016/j.vaccine.2011.10.086. Epub 2011 Nov 8.

PMID:
22075089
11.

Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model.

Pan Q, Pais R, Ohandjo A, He C, He Q, Omosun Y, Igietseme JU, Eko FO.

Vaccine. 2015 Apr 8;33(15):1865-72. doi: 10.1016/j.vaccine.2015.02.007. Epub 2015 Feb 17. Erratum in: Vaccine. 2015 Jun 4;33(24):1849.

12.

Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.

Yu H, Karunakaran KP, Jiang X, Shen C, Andersen P, Brunham RC.

Infect Immun. 2012 Apr;80(4):1510-8. doi: 10.1128/IAI.06338-11. Epub 2012 Jan 30.

13.

Towards a Chlamydia trachomatis vaccine: how close are we?

Cochrane M, Armitage CW, O'Meara CP, Beagley KW.

Future Microbiol. 2010 Dec;5(12):1833-56. doi: 10.2217/fmb.10.148. Review.

PMID:
21155665
14.

A multi-subunit chlamydial vaccine induces antibody and cell-mediated immunity in immunized koalas (Phascolarctos cinereus): comparison of three different adjuvants.

Carey AJ, Timms P, Rawlinson G, Brumm J, Nilsson K, Harris JM, Beagley KW.

Am J Reprod Immunol. 2010 Feb;63(2):161-72. doi: 10.1111/j.1600-0897.2009.00776.x.

PMID:
20064144
15.

Development status and future prospects for a vaccine against Chlamydia trachomatis infection.

Hafner LM, Wilson DP, Timms P.

Vaccine. 2014 Mar 20;32(14):1563-71. doi: 10.1016/j.vaccine.2013.08.020. Epub 2013 Aug 22. Review.

PMID:
23973245
16.

A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.

Ekong EE, Okenu DN, Mania-Pramanik J, He Q, Igietseme JU, Ananaba GA, Lyn D, Black C, Eko FO.

FEMS Immunol Med Microbiol. 2009 Mar;55(2):280-91. doi: 10.1111/j.1574-695X.2008.00493.x. Epub 2008 Nov 18.

17.

Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: evaluation of immunity and pathology.

Kollipara A, George C, Hanger J, Loader J, Polkinghorne A, Beagley K, Timms P.

Vaccine. 2012 Feb 27;30(10):1875-85. doi: 10.1016/j.vaccine.2011.12.125. Epub 2012 Jan 9.

PMID:
22230583
18.

Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Farris CM, Morrison RP.

Infect Immun. 2011 Mar;79(3):986-96. doi: 10.1128/IAI.00881-10. Epub 2010 Nov 15. Review.

19.

Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.

He Q, Martinez-Sobrido L, Eko FO, Palese P, Garcia-Sastre A, Lyn D, Okenu D, Bandea C, Ananaba GA, Black CM, Igietseme JU.

Immunology. 2007 Sep;122(1):28-37. Epub 2007 Apr 23. Erratum in: Immunology. 2007 Oct;122(2):302.

20.

Oral immunization with a novel lipid-based adjuvant protects against genital Chlamydia infection.

Hickey DK, Aldwell FE, Beagley KW.

Vaccine. 2010 Feb 17;28(7):1668-72. doi: 10.1016/j.vaccine.2009.12.010. Epub 2009 Dec 21.

PMID:
20026449

Supplemental Content

Support Center